Polymorphs and salts of 6(1hindol-4-yl)4(5{[4(1methylethyl)1piperazinyl]methyl}1,3oxazol2yl)1hindazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
The present invention relates to a polymorph of a compound of formula (II), which is a PI3-kinase activity inhibitor, and salts and polymorphs thereof: